Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1982 Jan 30;284(6312):303–306. doi: 10.1136/bmj.284.6312.303

Insulin given intranasally induces hypoglycaemia in normal and diabetic subjects.

A E Pontiroli, M Alberetto, A Secchi, G Dossi, I Bosi, G Pozza
PMCID: PMC1495887  PMID: 6800439

Abstract

Regular or crystalline insulin with sodium glycocholate as surfactant administered intranasally to normal volunteers induced hypoglycaemia and an increase in serum immunoreactive insulin concentrations. Serum C-peptide concentrations decreased or remained unchanged. Insulin administered intravenously to three of these subjects yielded a potency ratio of 1:8 for intranasal and intravenous insulin. In four insulin-dependent diabetics a cross-over study was performed on different days, insulin being administered once intranasally and once subcutaneously in a ratio of 1:9. In these patients the intranasal insulin was more effective than the subcutaneous insulin in preventing hyperglycaemia after breakfast. In four other insulin-dependent diabetics 11-hours monitoring was performed twice on two different days, insulin being administered in divided dosage sufficient to achieve a reasonable glycaemic profile. The administration during the morning, whereas subcutaneous insulin was more effective than intranasal during the afternoon.

Full text

PDF
303

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Crane C. W., Luntz G. R. Absorption of insulin from the human small intestine. Diabetes. 1968 Oct;17(10):625–627. doi: 10.2337/diab.17.10.625. [DOI] [PubMed] [Google Scholar]
  2. Engel R. H., Riggi S. J., Fahrenbach M. J. Insulin: intestinal absorption as water-in-oil-in-water emulsions. Nature. 1968 Aug 24;219(5156):856–857. doi: 10.1038/219856a0. [DOI] [PubMed] [Google Scholar]
  3. Fink G., Gennser G., Liedholm P., Thorell J., Mulder J. Comparison of plasma levels of luteinizing hormone releasing hormone in men after intravenous or intranasal administration. J Endocrinol. 1974 Nov;63(2):351–360. [PubMed] [Google Scholar]
  4. Fogt E. J., Dodd L. M., Jenning E. M., Clemens A. H. Development and evaluation of a glucose analyzer for a glucose controlled insulin infusion system ((Biostator). Clin Chem. 1978 Aug;24(8):1366–1372. [PubMed] [Google Scholar]
  5. HALES C. N., RANDLE P. J. Immunoassay of insulin with insulin-antibody precipitate. Biochem J. 1963 Jul;88:137–146. doi: 10.1042/bj0880137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Harai S., Ikenaga T., Matsuzawa T. Nasal absorption of insulin in dogs. Diabetes. 1978 Mar;27(3):296–299. doi: 10.2337/diab.27.3.296. [DOI] [PubMed] [Google Scholar]
  7. Heding L. G. Radioimmunological determination of human C-peptide in serum. Diabetologia. 1975 Dec;11(6):541–548. doi: 10.1007/BF01222104. [DOI] [PubMed] [Google Scholar]
  8. Keen H., Glynne A., Pickup J. C., Viberti G. C., Bilous R. W., Jarrett R. J., Marsden R. Human insulin produced by recombinant DNA technology: safety and hypoglycaemic potency in healthy men. Lancet. 1980 Aug 23;2(8191):398–401. doi: 10.1016/s0140-6736(80)90443-2. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES